603939.SH
益丰药房
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 23.65
−1.17%Sep 1, 2026, 09:07 UTC
Yifeng Pharmacy announced that as of August 31, 2026, it had repurchased 3.9773 million shares for 89.992 million yuan under its ongoing buyback program.
Source:Aug 27, 2026, 09:42 UTC
Yifeng Pharmacy proposed a cash dividend of 0.30 yuan per share (tax included).
Source:Aug 27, 2026, 09:42 UTC
Yifeng Pharmacy announced its first-half 2026 results with net profit of 964 million yuan, up 9.51% year-on-year.
Jul 26, 2026, 05:49 UTC
Multiple Shanghai-listed companies announced share buyback plans in the week ending July 26, 2026, with total proposed buyback amounts up to 83.86 billion yuan.
Jul 26, 2026, 05:49 UTC
Yifeng Pharmacy announced a share buyback plan of 200 million to 300 million yuan on July 24, 2026, for employee stock ownership or equity incentive.